Idiopathic pulmonary hemosiderosis patients present with symptoms associated with pulmonary suffering and signs of anemia, usually before reaching the age of 10 years [1]. Respiratory complaints, often recurrent or chronic, include coughing (dry or productive), wheezing, dyspnea, tachypnea, and hemoptysis, sometimes being wrongly diagnosed with lower respiratory infections [2]. However, hemoptysis is sometimes absent in children due to the fact that they swallow their sputum [3], but this does not exclude the presence of the disease. Symptoms may occur in an insidious or acute manner and initial presentation may be dramatic, with cyanosis, hypoxemia, respiratory failure, tachycardia, and fever. Clinical diagnosis is difficult in these cases, especially since pulmonary auscultation reveals crackles (caused by fibrosis [4] [5]) and pneumonia is easily suspected. Chronic but limited lung bleeding leads to more non-specific findings, like pallor, asthenia, exercise intolerance, failure to thrive, unsatisfactory ponderal and statural curves and finger clubbing.

Idiopathic pulmonary hemosiderosis may be accompanied by other illnesses, such as celiac disease [6] or von Willebrand disease. These associations induce more severe anemia, as the first one is a bleeding disorder per se, and the second one leads to enteral blood loss. Celiac disease may also cause flatulence, steatorrhea, and diarrhea, but the presence of these findings is not compulsory. Other associations include chronic granulomatous disease [7], idiopathic [8] and rheumatoid arthritis [9].

Idiopathic pulmonary hemosiderosis is a diagnosis of exclusion. Therefore cow milk protein allergy and autoimmune diseases, as well as other frequently associated illnesses like systemic lupus erythematosus, celiac disease, Goodpasture syndrome or Wegener granulomatosis must be ruled out. Towards this purpose, the physician may find it useful to order serum precipitins to casein and lactalbumin titers, anti-glomerular basal membrane, antinuclear antibodies, anti-DNA, anti-gliadin, anti-reticulin and anti-endomysial antibodies. The complete cell blood count will reveal the presence of anemia and possible eosinophilia. The anemia has iron deficiency characteristics (hypochromic and microcytic) [10]. Enteral blood loss is detected using guaiac tests. Keeping in mind that sputum is often swallowed by children, a gastric lavage analysis and bronchoalveolar lavage may prove useful, as they demonstrate the presence of presence of hemosiderin-bearing macrophages [4]. Despite the fact that pulmonary biopsy remains the gold standard for diagnosis [11], it can also be achieved using bronchoalveolar lavage [12] [13]. If sputum can be obtained, a cytological and bacteriologic analysis is necessary. Urinalysis may reveal proteinuria or hematuria. Coagulation disorders should also be investigated.

Chest radiography reveals bilateral alveolar infiltrates which are seen as opacities located in the basal and perihilar areas, that may be accompanied by edema [8]. After blood absorption, during remission phase, a reticular pattern remains. [4] Hilar adenopathy may be present in the acute phase. A more accurate diagnosis may be obtained with computed tomography, that also characterizes bronchial and vascular status, but pulmonary embolism is best excluded by ventilation/perfusion nuclear scanning.

Spirometry testing reveals a restrictive pattern between acute episodes and a mixed pattern during pulmonary hemorrhagic events.

The primary treatment for IPH involves managing symptoms and preventing further lung damage. Corticosteroids, such as prednisone, are commonly used to reduce inflammation and suppress the immune response. In some cases, additional immunosuppressive medications may be necessary. Supportive care, including oxygen therapy and blood transfusions, may be required for severe anemia or respiratory distress. Regular follow-up with a healthcare provider is essential to monitor the disease and adjust treatment as needed.

The prognosis for IPH varies widely among patients. Some individuals experience mild symptoms with long periods of remission, while others may have frequent and severe episodes of lung bleeding. Early diagnosis and appropriate treatment can improve outcomes and quality of life. However, chronic lung damage and complications from anemia can occur, potentially leading to long-term health issues.

The exact cause of IPH remains unknown, which is why it is termed "idiopathic." Researchers believe that an abnormal immune response may play a role in the disease, leading to inflammation and bleeding in the lungs. Genetic factors and environmental triggers have also been suggested, but no definitive cause has been identified.

IPH is a rare condition, with an estimated incidence of 0.24 to 1.23 cases per million people per year. It is more commonly diagnosed in children, with a slight male predominance. The disease can occur at any age, but most cases are reported in individuals under the age of 10. Due to its rarity, IPH is often underdiagnosed or misdiagnosed.

In IPH, repeated episodes of bleeding into the alveoli (tiny air sacs in the lungs) lead to the accumulation of hemosiderin, an iron-storage complex. This process results in inflammation and scarring of lung tissue, impairing the lungs' ability to exchange oxygen and carbon dioxide. The exact mechanism triggering the bleeding is not well understood, but it is thought to involve an abnormal immune response.

Currently, there are no known methods to prevent IPH due to its idiopathic nature. Early recognition of symptoms and prompt medical evaluation are crucial for managing the disease and preventing complications. Patients diagnosed with IPH should work closely with their healthcare providers to monitor their condition and adjust treatment as necessary.

Idiopathic Pulmonary Hemosiderosis is a rare and challenging lung disease characterized by recurrent bleeding into the lungs. While the cause remains unknown, early diagnosis and treatment can help manage symptoms and improve quality of life. Patients typically require a combination of medications and supportive care to control the disease and prevent complications.

If you or a loved one has been diagnosed with Idiopathic Pulmonary Hemosiderosis, it is important to understand the nature of the disease and the available treatment options. Regular follow-up with healthcare providers is essential to monitor the condition and adjust treatment as needed. While living with IPH can be challenging, many patients manage their symptoms effectively with appropriate medical care.

1. Bakalli I, Kota L, Sala D, et al. Idiopathic pulmonary hemosiderosis—a diagnostic challenge. Italian Journal of Pediatrics. 2014;40:35.
2. Yao T, Hung I, Wong K, et al. Pitfalls in the diagnosis of idiopathic pulmonary haemosiderosis. Arch Dis Child. 2002;86:436–438.
3. Chen K, Hsiao C, Huang S, et al. Anemia as the sole presenting symptom of idiopathic pulmonary hemosiderosis: report of two cases. Chang Gung Med J. 2004;27:824–829.
4. Ioachimescu O, Sieber S, Kotch A. Idiopathic pulmonary haemosiderosis revisited. European Respiratory Journal. 2004;24(1):162–170.
5. Bulucea C, Sorin D. Idiopathic pulmonary hemosiderosis in children: a Romanian experience. Pediatrics. 2008;121:158–159.
6. Ertekin V, Selimoglu M, Gursan N, Ozkan B. Idiopathic pulmonary hemosiderosis in children with celiac disease. Respiratory Medicine. 2006;100(3):568–569.
7. Hartl D, Belohradsky B, Griese M, et al. Celiac disease and pulmonary hemosiderosis in a patient with chronic granulomatous disease. Pediatric Pulmonology. 2004;38(4):344–348.
8. Chu S, Shyur S, Peng Y, et al. Juvenile idiopathic arthritis with pulmonary hemosiderosis: a case report. Journal of Microbiology, Immunology and Infection. 2002;35(2):133–135.
9. Topaloğlu R, Kiper N, Göçmen A, et al. Pulmonary hemosiderosis with juvenile rheumatoid arthritis: a case report. Turkish Journal of Pediatrics. 2000;42(2):148–150.
10. Sankararaman S, Shah K, Maddox K, et al. Clinical case of the month. Idiopathic pulmonary hemosiderosis presenting as a rare cause of iron deficiency anemia in a toddler-a diagnostic challenge. J La State Med Soc. 2012;164(5):293–296.
11. Afzal N, Mushtaq A, Rahman A, et al. Idiopathic pulmonary haemosiderosis presenting as severe iron deficiency anaemia–a case from Pakistan. J Pak Med Assoc. 2012;62(8):845–847.
12. Khonglah Y, Raphael V, Bhuyan A, et al. Idiopathic pulmonary haemosiderosis: diagnosis by gastric lavage. Afr J Resp Med. 2013;8(2):26–27.
13. Keller C, Langston C. Childhood idiopathic pulmonary hemosiderosis. N Engl J Med. 2000;343:781.